1. Effect of a 24 week home-based walking program on the incidence of aromatase inhibitor induced musculoskeletal pain: The WISE prospective, randomized, multicenter trial [SAKK 95/17]. (November 2022) Authors: Honecker, F.; Müller, A.; Schär, S.; Rosset, L.; Corke, M.N.; Schwitter, M.; Güth, U.; Jakob, A.; Balmelli-Cattelan, C.; Leo, C.; Fehr, M.; Thorn, D.R.; Riniker, S.; Chouiter-Djebaili, A.; Musilova, J.; Ribi, K.; Hoefnagels, N. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial. (April 2023) Authors: Hoefnagels, N.; Gautier, A.; Müller, A.; Schär, S.; Rosset, L.; Mahbiz, N. Corke; Schwitter, M.; Güth, U.; Jakob, A.; Balmelli-Cattelan, C.; Leo, C.; Fehr, M.; Thorn, D.R.; Riniker, S.; Chouiter-Djebaili, A.; Musilova, J.; Honecker, F. Journal: Breast Issue: Volume 68(2023) Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗